European Medicines Agency’s data protection notice for the Referentials Management System (RMS) activities
Human medicines European public assessment report (EPAR): VeraSeal, human fibrinogen,human thrombin, Date of authorisation: 10/11/2017, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Resolor, prucalopride, Date of authorisation: 14/10/2009, Revision: 30, Status: Authorised
Sixth European Medicines Agency - EuropaBio bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 October 2024, 10:00 (CEST) to 1 October 2024, 12:00 (CEST)
PRIME eligibility requests: 2025 deadlines for submission and timetable for assessment
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation: 30/09/2008, Revision: 42, Status: Authorised
Agenda of the Medicine Shortages SPOC Working Party meeting - 11 September 2024
Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA)
Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP